|
|
 |
Impact Statements
Peter A. Schad, PhD
Health Informatics Coordinator, National Cancer Institute, Division of Cancer Control and Population Sciences
 "The most impressive part of Connecting for Health to me is how it helps people to listen and learn from the projects and points of view of others. There is an enormous amount of public and private activity today in health information technology and data aggregation and analysis. It's very easy for projects to go their own way, without coordinating or learning from other initiatives working with similar problems. We are relatively new to the Connecting for Health work, but see that the Common Framework is a model that has benefited from a wide range of inputs and needs. I am most enthusiastic and encouraged that these issues are being raised to the consciousness of the public, health community and policy makers. I look forward to being an active participant as the Common Framework evolves to increasingly achieve the population health goals we share with so many of our colleagues around the table." Dr. Schad has over 20 years experience in the areas of biotechnology and Medical informatics including business development, genomics, cancer, molecular biology, bioinformatics, medical imaging, protein biochemistry, genetics, target validation, biomarker discovery, and in silico biology. He uniquely combines his scientific and technical expertise to the management of biological research and medical informatic programs. Currently Dr. Schad is providing strategy and acting as a liaison and coordinator for Health Informatics at the National Cancer Institute / Division of Cancer Control and Population Sciences. Dr. Schad previously was the Principal Investigator of Genome Sequence DataBase, a DOE funded project and one of four human genome databases at that time. As a Chief Scientific Officer, Dr. Schad developed the IT strategy and developed a multi-team infrastructure that classified its unique gene inventory into druggable targets. Dr Schad was also responsible for implementing a computationalbiology program as a discovery tool for genomic, proteomic studies and biomarker validation. Dr. Schad has recently been applying Advanced Mathematical Models to analyze and identify unique data sets within large and complex biological and medical data. Dr Schad has used AMM to find a malignant signature within prostate cancer expression data, develop better silencing iRNA oligos, explored protein localization of unknown proteins, and identification of unknown pathways and utilized AMM's to identify surrogate biomarkers for disease. Dr. Schad currently sits of several ad hoc NIH study sections for NCI, NIAID and NIDCR and Scientific Advisory Boards.
|
|
